The Transfusion Therapies business has been flat at roughly $550M (million) in sales for the past five years, and it is one of the lower-margin contributors at Baxter as well.  -   Michael Weinstein     Quotes
The Transfusion Therapies business has been flat at roughly $550M (million) in sales for the past five years, and it is one of the lower-margin contributors at Baxter as well. Michael Weinstein
 Business